Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
This report contains market size and forecast of Drugs for Herpes Labialis (Oral Herpes) in India, highlights the following information:
Sales of Drugs for Herpes Labialis (Oral Herpes) in India: Value 2019 VS 2023 VS 2030, ($ millions)
Sales of Drugs for Herpes Labialis (Oral Herpes) in India: Revenue Market Share by Company, 2019-2024
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Drugs for Herpes Labialis (Oral Herpes) will continue to grow rapidly in the future.
The global Drugs for Herpes Labialis (Oral Herpes) market size was valued at 2458 million in 2023 and is forecast to a readjusted size of US$ 3449.3 million by 2030, with a CAGR of 4.9% during the forecast period 2024-2030.While the India Drugs for Herpes Labialis (Oral Herpes) market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of Drugs for Herpes Labialis (Oral Herpes)'s global value in 2030, from % in 2023.
Our research team has surveyed the Drugs for Herpes Labialis (Oral Herpes) manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
India Drugs for Herpes Labialis (Oral Herpes) Market, By Type, 2019-2024, 2025-2030 ($ Millions)
India Drugs for Herpes Labialis (Oral Herpes) Market Segment Percentages, By Type, 2023 (%)
India Drugs for Herpes Labialis (Oral Herpes) Market, By Application, 2019-2024, 2025-2030 ($ Millions)
India Drugs for Herpes Labialis (Oral Herpes) Market Segment Percentages, By Application, 2023 (%)
The report also provides analysis of leading market participants including:
Key companies Drugs for Herpes Labialis (Oral Herpes) revenues in India market, 2019-2024 (Estimated), ($ millions)
Further, the report presents profiles of competitors in the market, key players include: